Evidence map›Paper›PMID 42094033›Full record

ArticleFrontiers in human neuroscience2026

Menopause-related brain fog as a midlife window in women's brain aging: toward ecologically valid measurement and digital phenotyping.

Parisa Gazerani

Abstract read
In one paragraph

Article in Frontiers in human neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Parisa GazeraniDepartment of Life Sciences and Health, Faculty of Health Sciences, Oslo Metropolitan University, Oslo, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cognitive complaints commonly described as "brain fog" are frequent during the menopause transition and often involve attention and memory difficulties that can affect daily functioning and quality of life. Midlife women may worry these symptoms signal early neurodegenerative disease, yet available evidence indicates that menopause-related cognitive changes are typically mild, variable, and distinct from dementia. Midlife, typically spanning approximately ages 40-60 years and encompassing the menopause transition (most commonly occurring between 45-55 years), represents a critical period for women's brain health. A major barrier to progress is that "brain fog" remains inconsistently defined and measured, limiting comparability across studies and constraining prevention-oriented strategies. In this Perspective, we propose that menopause-related brain fog represents a time-limited, clinically meaningful "measurement window" in women's brain aging trajectories, in which symptoms may be most detectable and potentially modifiable if assessed with tools that capture real-world fluctuation. We propose a pragmatic, multi-layer measurement framework that integrates (1) patient-centered symptom and functional impact profiling, (2) brief targeted cognitive assessment of vulnerable domains, and (3) ecological momentary assessment combined with passive and active digital measures using wearable and smartphone-based metrics (sleep, activity/circadian regularity, autonomic proxies, and brief repeated digital cognitive tasks). We outline validation principles, equity considerations, and reporting recommendations aligned with sex- and gender-aware research practices. By operationalizing menopause-related brain fog and linking it to feasible digital measurement strategies, aging neuroscience can better distinguish normative midlife cognitive variability from concerning trajectories, accelerate mechanistic research, and support preventive brain health interventions for women.

Indexed as

aging neurosciencebrain fogcognitive complaintsdigital phenotypingecological momentary assessmentmenopausewearableswomen's brain health

Identifiers

PMID42094033
PMCPMC13139119

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.